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STATE LEVEL EFFICIENCY MEASURES FOR HEALTHCARE SYSTEMS 
KAMIL MAKIEŁA 
Grand Valley State University 
 
   This article presents a parametric approach to healthcare system productivity analysis across 
the USA between 2000 and 2003. Though similar productivity analyses have been made on a 
country level, little research is devoted to state-level healthcare efficiency analysis. Hence, the 
aim of this exercise is to compute the so-called technical frontier also known as the best practice 
frontier which represents maximum obtainable output given inputs. The difference between each 
state’s health level and its potentially attainable maximum denotes a given state healthcare 
inefficiency. The Stochastic Frontier approach used in this article allows the computation of 
efficiency scores as well as accounting for random disturbances in the data.  
 
INTRODUCTION 
 
   There are several ways to consider frontier analysis and at least two of them have been applied 
in healthcare performance studies. These are either cost or production efficiency. The aim of cost 
efficiency analysis is to assess how much (minimum) cost it takes to produce output (or set of 
outputs) given inputs and market prices. Then by measuring the difference between the minimum 
cost and the observed real cost we can asses each unit’s inefficiency. Those estimates carry two 
effects: 
 
• Technical efficiency (deviation from “the best practice technology”) 
• Allocative efficiency which is concerned with price allocation (see, e.g. Greene, 2008) 
 
   Such analyses are known to have been applied to microeconomic healthcare studies such as 
hospital or nursing home performances benchmarks. (See Koop, Osiewalski, & Steel, 1997 or 
Farsi & Filippini, 2003.)  
   The second approach, productivity analysis, usually deals with healthcare systems or sectors as 
a whole, treating them as “aggregated” production units. For a very readable survey of 
performance methods pointing out advantages of such an approach I turn the reader to Pestiau 
(2009). The article also provides an overview of variables that could be used in such an analysis.  
In short, the production approach seems to be appropriate for two reasons: 
 
• It is the least demanding in terms of model specification and detailed knowledge of any 
process constraints (price levels, market structure etc.). The only real constraint in the 
productivity analysis is the assumption that there exists an underlying (unknown) 
production process which convergences inputs into output and that there also exists a 
limit to maximizing output given a set of inputs, generally known as the best practice 
frontier (or equivalently a limit to minimizing inputs while the output is maintained); 
 
• It allows measurment of pure technical efficiency. This is particularly important when we 
consider the fact that government interventions in the healthcare market may significantly 
distort optimal prices allocation. This in turn leads us to the problem of allocative 
inefficiency and shadow prices (see, e.g., Greene, 2008); 
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• Given the aggregate level of the analysis (a state-level comparison) where whole 
healthcare systems’ performances are studied, such an approach seems preferable by the 
researchers; see, e.g., Greene  (2004), Evans, Tandom, Murray, & Lauer (2000) or 
Kotzian (2005).  
 
For the reasons mentioned above I apply the productivity analysis framework to the 50 states 
plus District of Columbia (DC hereafter) of the USA for years 2000 – 2003.  
   The list of variables to consider varies from one study to another. The biggest problem (apart 
from data availability itself) is to asses which of the variables actually serve as production inputs 
and which of them should be considered as environmental factors (Evans, Tandom, Murray, & 
Lauer, 2000). Moreover, whether (or not) there should be some sort of frontier heterogeneity 
introduced across the observations (Greene, 2004). 
   Commonly considered outputs are life expectancy and infant survival rates (Afonso & St. 
Aubyn, 2008) or, in case of World Health Organization related studies, Disability Adjusted Life 
Expectancy (DALE) or Composite Health Care Attainment indices are more preferable (COMP); 
see, e.g., Evans, Tandom, Murray, & Lauer (2000) or Greene (2004).  
   Partially constrained by the data availability1 for the state health care attainment I define the 
dependent variable as a survival rate of infants within the first year of their life (per 100,000). 
The data were acquired through inversion of death rates statistics from the Centers for Disease 
Control and Prevention. Such an operation was necessary due to “production” characteristic of 
the model. Moreover, infant survival rates (ISR) are generally agreed-upon health indicators and 
seem to be rather commonly used; see, e.g., Afonso and St. Aubyn (2008) or Pastiau (2009).  
   I consider three main factors influencing health care: 
 
• Total state-level healthcare expenditures per 100,000 (this variable also can be viewed as 
a per capita cost indicator of how expensive the healthcare system is) 
• Labor defined here as the total number of physicians and nurses per 100,000 
• Number of hospital beds per 100,000.  
 
   I also considered three environmental factors influencing efficiency distribution across states: 
• Does a given state have Certificate of Need (CoN) laws or not? 
• Does a given state have a low poverty rate or not? 
• Is the state’s physician-to-nurse ratio high or not? 
 
A summary of the data used in the study can be viewed in Table 1.  
 
DATA DISCUSSION 
 
   There are some constraints to the analysis itself that should be mentioned before moving on to 
the analytical part of this paper. First, infant survival rates (ISR) can be questioned as being the 
only health care attainment indicator, and second this exact list of input variables to consider can 
also be challenged or, more likely, be regarded as insufficient. Even though this is by far the best 
                                                           
1
 And some ill-defined techniques of how to represent two indicators as one aggregate output. Considering that a 
bad aggregation procedure can produce biased results I decided to remain with one, but confident indicator of 
health level in a given state.  
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dataset for healthcare productivity analysis one can hope to gather today, I do acknowledge these 
issues and provide the following justifications to the approach presented in this study.  
   As far as the health indicator is concerned, I was reluctant to produce any joint output indicator 
and not only due to data scarcity. Although one may want to combine state-level life expectancy 
(LE) estimates (e.g., available for the year 2000) in the output variable the question remains how 
to do it. Simply adding them could create a considerable bias since we would then by default 
assume a fixed, linear, one-to-one trade-off between life expectancy and infant survival rate. This 
is theoretically unjustified at its least. A proper approach would be to allow for multiple outputs 
in the model itself but this would require switching to cost, distance or profit efficiency analyses. 
These, however, are far more demanding models in terms of data and underlying economic 
assumptions. This would also preclude pure technical efficiency analysis as mentioned earlier. 
Moreover, most of the existing output indicators tend to measure a state’s health level by its 
inputs, implicitly assuming a fixed performance ratio between inputs and the very thing they 
want to measure, namely health. Such output indicators are of no use in a regression analysis 
since the results would simply replicate the implicit underlying assumption.  
   The list of main input factors was chosen based on the previously mentioned articles. Even 
though one may find studies where other variables were also recognized as the main input factors 
of healthcare system, I must point out that it is not the aim of this research to test these concepts. 
The purpose of this exercise is to estimate the best practice frontier as well as the efficiency 
measures given the most widely acknowledged list of input factors and the best-available health 
output indicator.  
 
MODELING PRINCIPLES AND IMPLICATIONS 
 
   Since there is no acting model framework for such analyses I consider three Bayesian Frontier 
models where each one represents a higher level of flexibility and generality. Bayesian Frontier 
models represent a parametric (also known as econometric) approach to Frontier Analysis and 
generally may be regarded simply as Bayesian approach to Stochastic Frontier Analysis (SFA). 
In order to maintain analytical comparison, all three models are based on the same three main 
input factors, discussed earlier, and the three exogenous variables as influencing efficiency 
distribution among states, here interpreted as environmental factors.  
   The first model considered in the analysis, labeled Mark1, is a direct SFA extension of a 
simple Cobb-Douglas production technology model (Cobb & Douglas, 1928). In general the 
model behaves well. Not only does it allow for a reliable inference on state-specific healthcare 
system efficiency but also for a “global” analysis of interaction between the model inputs and 
their contribution to healthcare attainment. Its drawback is that it accounts for 45% (calculated as 
the FIT2 value) of the variation in the data leaving quite a significant portion unexplained. 
Moreover, the input parameters’ (factors’ elasticities) interaction and influences are considered 
globally for the whole sample.  
   In the second model, labeled Mark2, I use a translog functional form. This allows us to 
increase the model flexibility (increasing the FIT value to over 60%) and to make a time and 
state specific inference on inputs contribution to health attainment. Also, the sample-wide 
conclusions in the translog model do not change proving that the results are fairly robust to the 
                                                           
2
 FIT value is base on a concept proposed by Koop, Osiewalsi and Steel (2000). In short it is similar to R^2 but since 
the inefficiency scores are included in its computation it does not necessarily has to increase in a more general 
model (though in this case does)  
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model functional (parametric) specification. Also the efficiency measures in the two models are 
highly correlated (0.97 correlation).  
   The price to pay for this flexibility (as well as state specific inference) is that not all of the 
reported elasticities appear to be statistically significant (under the usual 5% significance level). 
Details are provided in Table 6 and Figure 8 (production elasticity of labor map). It seems that 
the model finds it particularly difficult to precisely assess input factors’ contribution to health 
attainment in southwestern states. Building a model that takes into account such heterogeneity 
could inform future research.  
   Both models do not explore the variation of the dependent variable in its full extend. There are 
at least three reasons for that. First, it should be noted that such macro-scale healthcare studies 
such as this one push the concept of productivity analysis probably to its reasonable limits. 
Second, the list of variables to consider in such an analysis is still fairly blurred, leaving much to 
the interpretation by the researcher. As mentioned before, the results presented here are based 
only on most commonly acknowledged indicators (infant mortality rates, the total amount of 
physicians and nurses as labor input, health expenditures, number of beds), which I found had 
been used repeatedly in studies similar to this one. Third, the analysis is based on an output 
indicator rather than a variable that could be unanimously considered by the health scholars as a 
“perfect measure” of health level in a given state. Furthermore, even availability of those state-
level health indicators (life expectancy, infant mortality rates) that could be traced through time 
(for a panel data study) poses a considerable limitation to the study. Although there has been an 
extensive progress made in terms of international measures of health (e.g., DALE index or 
COMP index; all published by WHO), state level benchmarks seem to have been neglected. 
Even life expectancy estimates are not being traced over time on a state level, let alone more 
complex measures of health.  
   In order to pursue a higher level of model flexibility and try to account for state-specific effects 
(thus essentially removing any time-invariant state differences from the inference on efficiency) I 
also consider Mark3 model where each state is given its own fixed effect3. In its essence, such a 
model specification captures all persistent (time-invariant) differences among states through a 
state-specific intercept (B0i) living the differences in efficiency to be determined by changes in 
the panel structure throughout the time. This, in turn, allows the frontier to vary among the 50 
states (plus DC).   
   Though such specification increases model explanatory power (to over 95%), there are several 
drawbacks to it. Introducing a separate effect for each state considerably increases the number of 
regression parameters to estimate, from eleven (in a standard three input translog model with a 
time trend variable) to sixty one. This, in turn, increases the uncertainty in the model regression 
estimates and more importantly in factors’ elasticities (which, in translog, are linear functions of 
the regression parameters and are of interest here). This precludes any statistically reliable 
inference on input factors’ contribution to the production. Nevertheless, the efficiency estimates 
are fairly precise and it is interesting to see how accounting for heterogeneity across the states 
augments the efficiency scores.  
 
 
                                                           
3
 This results in a two-sided effect model also referred to as a true fixed effect model In the context of Stochastic 
Frontiers; see Greene (2008) 
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ENVIRONMENTAL FACTORS’ CONTRIBUTION TO HEALTHCARE 
PERFORMANCE 
 
   By applying methodology developed by Koop, Osiewalski & Steel (2000) and pursued by, e.g., 
Marzec & Osiewalski (2008),  I introduce several exogenous variables for all three models which 
I believe should be influential to efficiency distribution across the states. Their impacts on 
efficiencies distribution among states are summarized in Figure 2.  
   One can notice that most influential among those variables seems to be the distinction between 
states that impose Certificate of Need laws and those that do not. Healthcare systems of those 
states that do not have Certificate of Need (CoN) laws have, on average, higher performances. 
This, however, should not be interpreted directly in the sense that CoN laws decrease a given 
state’s healthcare efficiency, since they may very well be there as a side effect of the 
phenomenon itself (thus serving as an indicator of a particular problem that those healthcare 
systems have). In other words, whether CoN laws and the underlying bureaucratic inefficiency 
are the reasons for such discrepancies or they are placed there to aid the problem (e.g., over-
expanded and thus very expensive hospital infrastructure) remains a case to study.  
   The remaining two exogenous variables (physician-to-nurse ratio and poverty ratio) have a 
rather moderate influence on efficiency that generally falls into a statistical error. The relative 
differences between them and the CoN law’s influence on efficiency are maintained throughout 
first two models Mark1 and Mark2. The pattern is broken in the last model where heterogeneity 
across the frontier is introduced. The conclusion here would be that poverty levels (which are 
assumed to influence efficiency) are state-specific phenomena which are persistent and do not 
change over time (at least not within the analysis time line); physician-to-nurse ratios quite the 
opposite. Moreover, introducing heterogeneity across the sample significantly increased the 
(global) average level of efficiency estimate which would mean that a great deal of differences in 
health care efficiencies among the states (seen in the first two models) is persistent over time. 
When heterogeneity was introduced most of the differences were simply “leveled-out.” Whether 
such time-invariant differences among states should be attributed to efficiency levels or 
considered separately (in order to better reflect the variation of the production frontier) is yet to 
be answered. Personally, I think that depends on answering several questions: 
 
1. Can our sample be regarded as homogeneous or reasonably simplified as such? In this 
case we are dealing with states of one (though big) country.  
2. Do the data allow for a statistically reliable inference? In this case the four year time 
frame appears to be too short.  
3. If not state-specific, what other type of heterogeneity of the frontier could be introduced? 
Here I found no other logical and theory-based distinction prior to the analysis (though 
distinctions between, e.g., blue vs. red states or east vs. west were also considered). The 
results I obtained from the Mark2 model suggest that a structural distinction between 
healthcare systems of North-East states and South-West would be interesting to apply. I 
leave it for future research.  
 
   To sum up, I believe that in this particular work it is more appropriate to consider a common 
frontier among all states and allow state specific effects to influence the efficiency measures. 
Moreover, the aim of this exercise is to compare all of the states to the best practice frontier and 
introducing any heterogeneity in the frontier would preclude such comparison. Therefore I base 
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my conclusions on the first two models, namely Mark1 and Mark2, while Mark3 is mainly used 
for comparative analysis of the results robustness to cross-state frontier shifts.  
 
EFFICIENCY ANALYSIS 
 
   The least efficient healthcare systems are reported to be in DC and Delaware. However, we 
should bear in mind that this does not mean that they are the worst in terms of healthcare 
attainment. This only indicates that their citizens’ health is relatively low in respect to the 
resources applied in their healthcare systems. This, in turn, may very well be the result of, for 
example, culture factors which are beyond the reach of any healthcare policy4. The most efficient 
state is Minnesota, followed by Kansas. The results for all three models can be viewed in Table 
5. 
   The correlation of the efficiency estimates between Mark1 and Mark2 model is over 0.97 
indicating that the results are quite robust to the parametric specification (technology functional 
specification). The efficiency estimates from Mark3 model are also positively correlated with the 
remaining two models’ estimates (0.44). Introducing state-specific effects, however, had a 
significant impact on some of the efficiency estimates. In particular: 
 
• It led to significantly increased efficiency scores for DC (from 0.82 to 0.91), Alabama 
(from 0.86 to 0.94), Delaware (from 0.82 to 0.92), Michigan (from 0.84 to 0.94), 
Mississippi (from 0.84 to 0.94) and South & North Carolina (from 0.86 to 0.94; from 
0.85 to 0.94); 
• It led to significantly decreased efficiency scores for New Hampshire (from 0.95 to 0.86) 
and Alaska (from 0.93 to 0.88).  
 
This could mean that there are persistent (time-invariant) effects among the 50 states (plus DC) 
that make their health delivery systems particularly more (or less) efficient than others.  
As we can notice from Figure 4 and Figure 5 the least efficient healthcare systems are reported to 
be among the “Old South” states. Spatial autocorrelation test confirms that the estimated 
efficiencies are geographically related in all three models.  
 
INPUT FACTOR CONTRIBUTION 
 
   It appears that labor intensity (expressed by the joint number of physicians and nurses per 
capita) is the main and positive contributor to the health attainment. Total state-level 
expenditures per capita on the other hand play a negative role in the process. Although at first 
one would think that an expensive healthcare system is a good healthcare system, the results 
become clearer when we consider the interaction between the two input factors. It turns out that 
elasticities between the two factors are negatively correlated (-0.8). This indicates that high 
levels of healthcare labor productivity result in lower healthcare costs per capita (or vice-versa). 
This would provide empirical evidence of a simple market based mechanism – high levels of 
supply ultimately result in lower prices. One would argue that expensive healthcare systems are 
the least accessible (particularly in the USA), imminently leading to the society being worse-off.  
                                                           
4
 Interestingly these factors would also make their inefficiencies persistent over time. As we learn later DC and 
Delaware indeed benefit greatly in Mark3 model, where time-invariant factors (state-specific effects) are 
accounted for and excluded from the efficiency estimates  
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   Beds-per-capita tends to play a moderate and, on average, negative role in healthcare 
attainment. This result is somewhat interesting if we consider average differences in efficiency 
scores among the states with and without CoN laws. Normally, one would think that the more 
hospitals there are the better off the society is as a whole. However, in-bed hospitalization in the 
USA is very expensive and accessible only for a small percentage of insured Americans who can 
afford it. A more detailed analysis reveals that all the healthcare systems in the panel seem 
saturated in terms of hospital beds and there is very little change over time. It then seems 
reasonable that those states which have expanded their in-bed healthcare infrastructure the most 
are those whose society (as a whole) is relatively worse-off than others. One could argue that this 
issue was, in fact, recognized by the legislature in those states by voting in the CoN laws. It may 
very well be that the over-built hospital infrastructure in those states is causing (1) on-average 
negative impact of additional in-bed healthcare infrastructure on the overall level of health of the 
society and (2) on-average low healthcare system performance in those states. This of course is 
just a theory that would account for the results and should be further investigated.  
   There is a clear geographical distinction of the two groups – those states for which we can 
accurately assess input factors contribution and those we cannot. The results for states lying 
more towards the southwest seem statistically insignificant (under 5% significance level) which 
would mean that the model (Mark2) fails to accurately assess healthcare inputs-output interaction 
in those states. The two groups can be viewed in Figure 7 and Figure 8 (dashed fields on the 
map). As mentioned, before introducing a prior structural distinction between the two groups 
could inform future research.  
  Time, on average, had a positive impact on healthcare attainment in the USA between 2000 and 
2003 (around 3.5% average annual progress). Furthermore, the estimated time parameter is 
negatively correlated with expenditures (per capita) elasticity (-0.74 for Mark1 and -0.76 for 
Mark2 model) which would mean that the impact of costs on healthcare attainment (per capita) 
decreased with time. Also, there is a slight positive correlation between time progress and labor 
per capita elasticity (0.53 for Mark1 and 0.55 for Mark2 model) which would mean that 
productivity of labor in general was on the rise throughout the analyzed period. Influence of beds 
per capita remained relatively constant in time (0.16 for Mark1 and 0.24 for Mark2 model). This 
seems reasonable since one would expect little change in the number of beds (i.e. number of 
hospitals or in-bed hospitalization capacity) among the states over such a short period of time.  
 
CONCLUSION 
 
The analysis shows that there are significant differences in performance levels among state-level 
healthcare systems. In particular we can draw the following conclusions in respect of their 
performances: 
 
1. Differences among states seem to carry a geographic pattern which was also proved by 
the spatial autocorrelation test. Those states that perform the worse are generally 
concentrated in the “Old South.” 
2. There is a distinctive pattern between states that have Certificate of Need (CoN) laws and 
those that do not, the latter being on average significantly more efficient. Though sources 
of this inefficiency in CoN law states remain uncertain, their low performances clearly 
stand out.  
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3. Efficiency differences among the states significantly decreased in Mark3 model where 
state-specific effects were introduced. This would provide an empirical evidence that 
most differences in healthcare performances are rather state specific and do not change 
significantly over time. 
To sum up, it should be noted that there is a great potential for Stochastic Frontier Analysis in 
providing state-level efficiency benchmarks as well as in helping to trace the sources of 
healthcare systems’ inefficiencies. This field of application, however, seems relatively new and 
requires extensive research.  
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APPENDIX 1: TABLES 
 
Table 1: Data summary 
Variable description Mean STD MIN MAX 
Health care output indicator     
Infant survival rate per 100,000 infants population1 144.24 30.56 65.33 257.80 
Health care inputs      
Total expenditures per 100,000 population2 458.16 92.05 302.63 997.44 
Number of physicians and nurses per 100,000 
population3 1111.21 248.62 692.24 2583.87 
Number of Hospital beds per 100,000 population4 312.21 103.38 180.00 610.00 
Environmental factors     
Physicians to nurses ratio 0.2951 0.0659 0.1686 0.4977 
Poverty ratio (% of population below poverty line)5 0.1174 0.0319 0.0633 0.1924 
Certificate of need laws: a strictly dichotomous variable; 13 states in the analyzed period; see the 
map 
 
 
 
Notes: In order to reduce the computation burden, environmental factors enter models as 
dichotomous variables indicating whether or not a given state (in a given year) falls into a 
category of (1) high physicians to nurses ratio, (2) low poverty status and (3) Certificate of need 
(CON) state.  
1
 Data computed with the use of infant death rates (rates per 100,000 population under 1 year) 
source: CDC mortality tables GMWK23R 
2
 National Health Expenditure Data, Health Expenditures by State, Centers for Medicare and 
Medicaid Services, Office of the Actuary, National Health Statistics Group, released February 
2007 
3
 American Medical Association, Chicago, IL, Physician Characteristics and Distribution in the 
U.S.  
4
 2007 AHA Annual Surveys. Data also available at 
http://www.statehealthfacts.org/comparetable.jsp?ind=396&cat=8  
5
 Calculated as a ratio of state’s population in poverty to its total population. Source: 2000 
Census.  
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Table 2: Mark1 model summary 
 
Estimated parameters Standard deviation T test statistics 
exp -0.4407 0.1962 2.2462 
lab 0.4722 0.1468 3.2169 
beds -0.3153 0.0497 6.3498 
one 6.1246 0.5946 10.3006 
time 0.0381 0.0174 2.1944 
 
SSE1 4.0281 
SSE0 8.9026 
FIT 0.4525 
Femp* 15.8404 
 
skewness of the error term in the simple model -0.0519 
 
Efficiency correlation matrix (Pearson) 
  
Mark1 Mark2 Mark3 FIT 
Mark1  1.0000 0.9732 0.4041 45% 
Mark2 0.9732 1.0000 0.4410 60% 
Mark3 0.4041 0.4410 1.0000 95% 
   
Efficiency correlation matrix (Spearman) 
  
Mark1 Mark2 Mark3 
Mark1 1.0000 0.9846 0.3972 
Mark2 0.9846 1.0000 0.4302 
Mark3 0.3972 0.4302 1.0000 
  
  
  
  
   
Full correlation matrix of the regression parameters 
  
EX LB BD dummy var. time 
EX 1.0000 -0.8094 -0.1123 -0.5022 -0.7396 
LB -0.8094 1.0000 -0.1982 -0.0390 0.5328 
BD -0.1123 -0.1982 1.0000 0.0753 0.1633 
One -0.5022 -0.0390 0.0753 1.0000 0.4124 
Time -0.7396 0.5328 0.1633 0.4124 1.0000 
 
Pearson Correlation (Exp, Lab) -0.8090 
Notes. SSE1 means Sum of Squared Errors from the model. These comments also refer to the 
following two tables. 
* Femp refers to a similar model with a “simple” two-sided error component. This indicates that 
the (simple) model is statistically valid which could provide a simple validation for the Bayesian 
Frontier model itself. Unfortunately, there is no simple test that would directly validate the full 
model. It can be done ad hoc by assessing (1) if the “simple” model is statistically valid, and (2) 
if its error term distribution is negatively skewed (indicating existence of inefficiency among 
units).  
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Table 3: Mark2 model summary 
SSE 3.5571         
SSE0 8.9026      
FIT 0.6004      
 
 
    
Femp* 23.5957 <= applies to a "non-frontier" model 
skewness of the error term in the simple model -0.0863 
        
Average factor elasticities      
   Elast D(elast)    
Expenditures -0.4742 0.3426    
Labor  0.6147 0.3001    
Beds  -0.3580 0.1200    
Time  0.0375 0.0175    
        
        
Correlation matrix of factors elasticities (at means)   
  Exp Lab Beds Time   
Exp 1.0000 -0.8241 -0.2019 -0.7602   
Lab -0.8241 1.0000 -0.1256 0.5535   
Beds -0.2019 -0.1256 1.0000 0.2445   
Time -0.7602 0.5535 0.2445 1.0000   
 
*See notes for Table 2 
 
 
Table 4: Mark3 model summary 
  SSE1   0.4299 
  SSE0  8.9026 
  FIT  0.9517 
  Femp*  15.4738 
      
Skewness of the error term in the simple model -0.1380 
 
*See notes for Table 2 
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Table 5: Efficiency estimates for the three models 
State Mark1 model Mark2 model Mark3 model 
 Rank Eff D(Eff) Rank Eff D(Eff) Rank Eff D(Eff) 
Alabama 45 0.8666 0.0915 45 0.8802 0.0847 31 0.9453 0.0432 
Alaska   28 0.9344 0.0601 33 0.9170 0.0709 51 0.8835 0.0705 
Arizona  34 0.9113 0.0721 32 0.9221 0.0649 8 0.9588 0.0364 
Arkansas 41 0.8918 0.0803 38 0.9068 0.0724 27 0.9466 0.0427 
California 2 0.9769 0.0245 2 0.9766 0.0253 2 0.9738 0.0276 
Colorado 3 0.9744 0.0297 6 0.9703 0.0332 10 0.9584 0.0388 
Connecticut 19 0.9481 0.0526 24 0.9385 0.0583 30 0.9459 0.0468 
Delaware 51 0.8291 0.1231 52 0.7995 0.1246 46 0.9262 0.0540 
District of Col. 52 0.8267 0.1138 48 0.8634 0.0937 48 0.9144 0.0545 
Florida   31 0.9210 0.0644 27 0.9282 0.0597 32 0.9450 0.0434 
Georgia  46 0.8657 0.0914 44 0.8817 0.0841 28 0.9464 0.0427 
Hawaii   32 0.9169 0.0672 31 0.9233 0.0630 47 0.9214 0.0545 
Idaho    10 0.9627 0.0380 7 0.9681 0.0331 7 0.9594 0.0374 
Illinois   38 0.8978 0.0799 39 0.9023 0.0764 19 0.9524 0.0394 
Indiana  5 0.9714 0.0338 8 0.9675 0.0367 6 0.9604 0.0368 
Iowa    17 0.9537 0.0440 20 0.9455 0.0494 44 0.9287 0.0513 
Kansas  4 0.9722 0.0302 3 0.9731 0.0295 1 0.9739 0.0275 
Kentucky 25 0.9389 0.0539 21 0.9449 0.0490 24 0.9493 0.0421 
Louisiana 42 0.8865 0.0864 40 0.8946 0.0811 12 0.9580 0.0367 
Maine   20 0.9469 0.0466 17 0.9489 0.0449 50 0.9093 0.0517 
Maryland 40 0.8951 0.0958 47 0.8663 0.1058 29 0.9460 0.0465 
Massachusetts 14 0.9578 0.0408 16 0.9508 0.0460 42 0.9396 0.0488 
Michigan 50 0.8455 0.0985 51 0.8557 0.0938 37 0.9427 0.0440 
Minnesota 1 0.9802 0.0221 1 0.9783 0.0235 15 0.9567 0.0401 
Mississippi 49 0.8465 0.0984 50 0.8570 0.0950 39 0.9423 0.0447 
Missouri 33 0.9120 0.0717 34 0.9168 0.0683 21 0.9508 0.0408 
Montana 24 0.9442 0.0498 19 0.9460 0.0482 23 0.9502 0.0416 
Nebraska 26 0.9373 0.0537 25 0.9379 0.0529 43 0.9304 0.0500 
Nevada 23 0.9442 0.0500 28 0.9279 0.0620 22 0.9504 0.0423 
New Hampshire 12 0.9593 0.0389 14 0.9564 0.0405 52 0.8680 0.0619 
New Jersey 15 0.9566 0.0437 15 0.9529 0.0451 25 0.9490 0.0440 
New Mexico 11 0.9602 0.0404 11 0.9650 0.0365 4 0.9626 0.0356 
New York 18 0.9519 0.0441 13 0.9570 0.0397 16 0.9559 0.0379 
North Carolina 48 0.8534 0.0958 49 0.8603 0.0922 38 0.9424 0.0437 
North Dakota 9 0.9663 0.0343 10 0.9667 0.0345 33 0.9448 0.0511 
Ohio  35 0.9084 0.0742 35 0.9135 0.0706 11 0.9582 0.0363 
Oklahoma 36 0.9033 0.0741 37 0.9125 0.0696 41 0.9410 0.0449 
Oregon 27 0.9368 0.0553 26 0.9371 0.0552 9 0.9587 0.0366 
Pennsylvania 13 0.9584 0.0424 12 0.9587 0.0429 3 0.9650 0.0331 
Rhode 39 0.8974 0.0815 42 0.8884 0.0863 17 0.9553 0.0383 
South Carolina 47 0.8629 0.0931 46 0.8727 0.0884 26 0.9473 0.0424 
South Dakota 6 0.9705 0.0300 9 0.9671 0.0343 20 0.9512 0.0442 
Tennessee 43 0.8842 0.0878 41 0.8940 0.0810 13 0.9578 0.0367 
Texas 22 0.9457 0.0485 22 0.9449 0.0490 18 0.9534 0.0392 
Utah  7 0.9686 0.0320 4 0.9722 0.0286 5 0.9615 0.0359 
Vermont 16 0.9560 0.0444 18 0.9460 0.0514 45 0.9268 0.0600 
Virginia 44 0.8744 0.0879 43 0.8854 0.0821 35 0.9439 0.0433 
Washington 29 0.9294 0.0594 29 0.9262 0.0608 36 0.9427 0.0444 
West Virginia 37 0.9031 0.0723 36 0.9128 0.0671 49 0.9125 0.0465 
Wisconsin 21 0.9467 0.0532 23 0.9416 0.0547 40 0.9411 0.0489 
Wyoming 8 0.9682 0.0324 5 0.9713 0.0296 14 0.9576 0.0392 
Averages 30 0.9239 0.0614 30 0.9253 0.0602 34 0.9444 0.0435 
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Table 6: Input Factor Elasticities; Mark2 model 
State Labor  Expenditures Number of beds 
 El D(El) El D(El) El D(El) 
Alabama 0.6315 0.2746 -0.4841 0.3073 -0.2993 0.0966 
Alaska   -0.0192 0.3325 -0.0991 0.4534 -0.5915 0.1449 
Arizona  0.2408 0.2961 0.2087 0.3656 -0.4498 0.1384 
Arkansas 0.5330 0.3039 -0.3236 0.3206 -0.2991 0.1173 
California -0.2036 0.2983 0.3788 0.3308 -0.5653 0.1371 
Colorado 0.3533 0.2340 -0.0797 0.2992 -0.4578 0.1261 
Connecticut 0.5716 0.3106 -0.5917 0.3649 -0.4823 0.1635 
Delaware 0.4697 0.2442 -0.4592 0.3206 -0.4691 0.1224 
District of Columbia 1.7227 0.6701 -2.3174 0.6983 -0.1784 0.2177 
Florida   0.3767 0.2629 -0.3659 0.3200 -0.4095 0.0882 
Georgia  0.3670 0.2200 -0.1389 0.2585 -0.3829 0.0835 
Hawaii   0.4100 0.1780 -0.2097 0.2439 -0.4164 0.0815 
Idaho    0.1979 0.2971 0.1938 0.3353 -0.3998 0.1154 
Illinois   0.7344 0.2041 -0.5290 0.2650 -0.3323 0.0680 
Indiana  0.5190 0.2145 -0.3990 0.2672 -0.3653 0.0709 
Iowa    1.1895 0.3160 -0.9387 0.3660 -0.1771 0.0841 
Kansas  0.9550 0.2905 -0.7744 0.3256 -0.2154 0.0950 
Kentucky 0.6825 0.2573 -0.6090 0.2898 -0.3053 0.0857 
Louisiana 0.7547 0.2917 -0.6448 0.3136 -0.2646 0.1047 
Maine   0.9204 0.2758 -0.8273 0.3133 -0.3315 0.1010 
Maryland 0.6506 0.3220 -0.4310 0.3587 -0.4303 0.1650 
Massachusetts 1.1109 0.4421 -1.0987 0.4367 -0.3583 0.1908 
Michigan 0.6513 0.2215 -0.3741 0.2900 -0.3577 0.0870 
Minnesota 0.7642 0.2385 -0.7601 0.2948 -0.3395 0.0693 
Mississippi 0.7729 0.3973 -0.5815 0.3936 -0.1981 0.1716 
Missouri 0.8335 0.2348 -0.7416 0.2838 -0.2986 0.0646 
Montana 0.9755 0.3731 -0.7862 0.3880 -0.1646 0.1511 
Nebraska 1.0448 0.3307 -0.9745 0.3408 -0.1885 0.1221 
Nevada -0.4976 0.4091 0.6526 0.4269 -0.6301 0.1721 
New Hampshire 0.6699 0.2700 -0.4531 0.3078 -0.4061 0.1350 
New Jersey 0.5924 0.2009 -0.5278 0.2686 -0.3936 0.0760 
New Mexico 0.2474 0.2926 0.2040 0.3590 -0.4553 0.1423 
New York 0.6913 0.2911 -0.8137 0.3613 -0.3675 0.0854 
North Carolina 0.7313 0.2118 -0.5219 0.2749 -0.3367 0.0728 
North Dakota 1.1764 0.4535 -1.2617 0.4457 -0.1398 0.1849 
Ohio  0.7039 0.2117 -0.6081 0.2737 -0.3577 0.0718 
Oklahoma 0.1342 0.3604 0.0102 0.3637 -0.4091 0.1392 
Oregon 0.3322 0.2703 -0.0408 0.3193 -0.4876 0.1584 
Pennsylvania 1.0601 0.2952 -0.9882 0.3275 -0.2763 0.0876 
Rhode 0.8561 0.3760 -0.7575 0.3929 -0.4067 0.1792 
South Carolina 0.2398 0.2399 -0.0902 0.2837 -0.4298 0.0926 
South Dakota 1.4867 0.4383 -1.3851 0.4400 -0.0519 0.1702 
Tennessee 0.6678 0.2438 -0.6312 0.2841 -0.3257 0.0767 
Texas -0.0671 0.3329 0.1838 0.3552 -0.4975 0.1288 
Utah  0.1143 0.3094 0.3581 0.3699 -0.4769 0.1474 
Vermont 1.0417 0.3807 -0.7842 0.4232 -0.3032 0.1435 
Virginia 0.5594 0.2505 -0.2228 0.3238 -0.3852 0.1091 
Washington 0.2247 0.2670 -0.0035 0.3271 -0.5235 0.1608 
West Virginia 0.7631 0.3458 -0.7521 0.3626 -0.2617 0.1293 
Wisconsin 0.6501 0.2104 -0.5535 0.2768 -0.3799 0.0801 
Wyoming 0.7605 0.3123 -0.4390 0.3572 -0.2286 0.1148 
Average 0.6147 0.3001 -0.4742 0.3426 -0.3580 0.1200 
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APPENDIX 2: FIGURES 
 
Figure 1: Average efficiency levels of healthcare systems 
 
 
 
 
Notes: “ONLY LP” means average for states with the lowest poverty levels,  
“ONLY HIGH P/N” means average for states with the highest physician-to-nurse ratio,  
“ONLY NO-CON” means average for states with no Certificates of Need laws,  
“NONE” are states which were not influenced by any of the environmental factors 
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Figure 2: Comparison between efficiency estimates between models 
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APPENDIX 3: MAPS 
 
Figure 3: States with Certificate of Need (CON) laws repealed or not in effect (black fields) 
 
 
 
 
Figure 4: Efficiency estimates from Mark1 model 
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    Figure 5: Efficiency estimates from Mark2 model 
 
 
  
  Figure 6: Efficiency estimates from Mark3 model 
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Figure 7: Elasticities of expenditure per capita; Hatched regions indicate that estimates are 
statistically insignificant under 5% significance level; Mark2 model 
 
 
 
 
Figure 8: Elasticities of labor; Mark2 model 
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